Phase-III Clinical Trial of Adjuvant FAM2 (5-FU, Adriamycin and Mitomycin C) vs Control in Resectable Gastric Cancer: A Study of the EORTC Gastrointestinal Tract Cancer Cooperative Group

Author(s):  
M. Lise ◽  
D. Nitti ◽  
M. Buyse ◽  
G. Cartei ◽  
A. Fornasiero ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document